2F8

2F8 Uses, Dosage, Side Effects, Food Interaction and all others data.

2F8 is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). 2F8 has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.

Trade Name 2F8
Generic Zalutumumab
Zalutumumab Other Names Zalutumumab
Type
Formula C6512H10074N1734O2032S46
Weight 146641.0546 Da
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
2F8
2F8

Innovators Monograph

You find simplified version here 2F8

*** Taking medicines without doctor's advice can cause long-term problems.
Share